| scholarly article | Q13442814 |
| P50 | author | Petra Schneider | Q55175597 |
| Chris J Drakeley | Q56774786 | ||
| Robert W Sauerwein | Q60043950 | ||
| John I Githure | Q87121460 | ||
| Alma Tostmann | Q91219713 | ||
| P2093 | author name string | Colin J Sutherland | |
| Louis C Gouagna | |||
| Rosalynn Ord | |||
| Sabah A Omar | |||
| J Teun Bousema | |||
| Rein Houben | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| artemisinin | Q426921 | ||
| P304 | page(s) | 1151-1159 | |
| P577 | publication date | 2006-03-15 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | |
| P478 | volume | 193 |
| Q44168409 | A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance |
| Q35203887 | A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania |
| Q28477853 | A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial |
| Q37010425 | A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya |
| Q33818046 | A research agenda for malaria eradication: vaccines |
| Q34020818 | A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission |
| Q26786586 | A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria |
| Q48018805 | Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Asexual and Transmissible Malaria Parasites. |
| Q38946050 | Additional burden of asymptomatic and sub-patent malaria infections during low transmission season in forested tribal villages in Chhattisgarh, India |
| Q37384816 | Antibody responses to surface antigens of Plasmodium falciparum gametocyte-infected erythrocytes and their relation to gametocytaemia |
| Q100755363 | Artemisinin exposure at the ring or trophozoite stage impacts Plasmodium falciparum sexual conversion differently |
| Q36353796 | Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission |
| Q24241785 | Artemisinin-based combination therapy for treating uncomplicated malaria |
| Q35676996 | Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia |
| Q37192206 | Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based cross-sectional survey in western Kenya, 2012. |
| Q37235000 | Asymptomatic Parasitemia in under five, school age children and households self-medication, Lubumbashi, Democratic Republic of Congo |
| Q44146283 | Asymptomatic malaria infections: detectability, transmissibility and public health relevance |
| Q27014789 | Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis |
| Q35634399 | Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea |
| Q53813788 | Chemical Composition and Antipathogenic Activity of Artemisia annua Essential Oil from Romania. |
| Q37489274 | Chemical signatures and new drug targets for gametocytocidal drug development |
| Q21143739 | Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria |
| Q30567158 | Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials |
| Q37470249 | Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau |
| Q34597617 | Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam |
| Q37119572 | Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study |
| Q61808246 | Does artemether-lumefantrine administration affect mosquito olfactory behaviour and fitness? |
| Q37085908 | Does the drug sensitivity of malaria parasites depend on their virulence? |
| Q35507886 | Drugs for malaria: something old, something new, something borrowed |
| Q57281219 | Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin |
| Q94554819 | Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related morbidities and improving cognitive ability in school-aged children in Tanzan |
| Q34164652 | Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial |
| Q33587420 | Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children |
| Q50107885 | Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial |
| Q36639790 | Enhanced detection of gametocytes by magnetic deposition microscopy predicts higher potential for Plasmodium falciparum transmission |
| Q34177472 | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination |
| Q36797637 | Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania |
| Q39110719 | Filter paper collection of Plasmodium falciparum mRNA for detecting low-density gametocytes |
| Q52564901 | Gametocyte Development and Carriage in Ghanaian Individuals with Uncomplicated Plasmodium falciparum Malaria. |
| Q28068072 | Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data |
| Q91695306 | Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment |
| Q36868099 | Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand |
| Q37272969 | Gametocytes: insights gained during a decade of molecular monitoring |
| Q37024345 | Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection |
| Q30392186 | HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection |
| Q33627561 | Heritability of the human infectious reservoir of malaria parasites |
| Q30378918 | Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria. |
| Q36826719 | High prevalence of asymptomatic malaria in a tribal population in eastern India |
| Q34641186 | Human immune responses that reduce the transmission of Plasmodium falciparum in African populations |
| Q35090435 | Impact of repeated NeemAzal-treated blood meals on the fitness of Anopheles stephensi mosquitoes |
| Q33826283 | In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals |
| Q36459407 | Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae |
| Q36858823 | Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination |
| Q34922792 | Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. |
| Q33928116 | Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission area |
| Q92969925 | Malaria burden and pre-hospital medication among subjects with malaria in Maiduguri, Northeast Nigeria |
| Q36832446 | Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development |
| Q33894262 | Malaria gametocytogenesis |
| Q33730646 | Malaria prevalence in asymptomatic and symptomatic children in Kiwangwa, Bagamoyo district, Tanzania |
| Q44168825 | Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial |
| Q37018637 | Malaria vaccines and their potential role in the elimination of malaria |
| Q33446846 | Malaria: uncomplicated, caused by Plasmodium falciparum. |
| Q36969808 | Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs |
| Q36450230 | Marked age-dependent prevalence of symptomatic and patent infections and complexity of distribution of human Plasmodium species in central Vietnam |
| Q39198350 | Measuring resistant-genotype transmission of malaria parasites: challenges and prospects |
| Q34351109 | Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
| Q36869616 | Modeling Key Malaria Drugs' Impact on Global Health: A Reason to Invest in the Global Health Impact Index |
| Q37509562 | Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination |
| Q47096821 | Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmission |
| Q40081071 | Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment |
| Q56440042 | Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in |
| Q28474141 | Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity |
| Q33960088 | Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers |
| Q35189138 | Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa |
| Q99591398 | Natural Products: A Potential Source of Malaria Transmission Blocking Drugs? |
| Q37315271 | No asymptomatic malaria parasitaemia found among 108 young children at one health facility in Dar es Salaam, Tanzania. |
| Q36969682 | Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes |
| Q28472247 | Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria |
| Q36222681 | Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia. |
| Q64081866 | Overview of artemisinin effectiveness during outset years of its implementation in the western Brazilian Amazon |
| Q41937695 | Pharmacodynamics of antimalarial chemotherapy |
| Q38066991 | Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs |
| Q55491440 | Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment. |
| Q37491136 | Plasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana |
| Q34993578 | Pregnant women are a reservoir of malaria transmission in Blantyre, Malawi |
| Q28469316 | Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate |
| Q42920110 | Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk |
| Q33875677 | Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool |
| Q36617963 | Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases? |
| Q36800842 | Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials |
| Q42127740 | Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence |
| Q21032443 | Response to malaria epidemics in Africa |
| Q33898575 | Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs |
| Q48000282 | Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments |
| Q92993514 | Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial |
| Q41940547 | Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria |
| Q34038938 | Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial |
| Q35948587 | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial |
| Q38245842 | Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination |
| Q36730218 | Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda |
| Q34493765 | Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon |
| Q28474692 | Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya |
| Q33520254 | Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission |
| Q37449902 | Successful malaria elimination in the Ecuador-Peru border region: epidemiology and lessons learned |
| Q28125936 | Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes |
| Q28534608 | Targeting asymptomatic malaria infections: active surveillance in control and elimination |
| Q36730061 | The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission |
| Q38840716 | The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis |
| Q42562371 | The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies |
| Q35930447 | The complexities of malaria disease manifestations with a focus on asymptomatic malaria |
| Q55420162 | The decline of malaria in Vietnam, 1991-2014. |
| Q28744581 | The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania |
| Q34486508 | The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial |
| Q36743875 | The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children |
| Q58732770 | The prevalence of submicroscopic Plasmodium falciparum gametocyte carriage and multiplicity of infection in children, pregnant women and adults in a low malaria transmission area in Southern Ghana |
| Q33724777 | The role of submicroscopic parasitemia in malaria transmission: what is the evidence? |
| Q40326153 | Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria |
| Q63634019 | Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study |
| Q33759036 | Transmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensi |
| Q38973256 | West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia |
| Q34509609 | Whole-cell in vitro screening for gametocytocidal compounds |
Search more.